India & India — Central Drugs Standard Control Organisation
14 shared events · Importance 5 · Last updated Aug 04, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
India: India approved its first dengue vaccine, addressing a major public health challenge. The country accounts for one-third of global dengue cases, and the vaccine could reduce disease burden and healthcare strain.
India — Central Drugs Standard Control Organisation: CDSCO, under the Ministry of Health, conducted the scientific evaluation and granted marketing authorization for QDENGA, enabling its introduction in India.
Jul 20, 2026 · 93 articles
Domestic
India: India is strengthening its digital public infrastructure for health by launching several new initiatives, including Aarogya Setu 2.0, a Drug Registry, and e-Sushrut Clinic, aiming to make healthcare more integrated, accessible, and citizen-centric.
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation collaborated in the development of the Drug Registry, ensuring standardization of medicine data across India's healthcare system.
Jun 27, 2026 · 32 articles
Regulatory
India: India is the host and central actor, seeking to strengthen its global pharmaceutical hub status through regulatory cooperation and trade agreements.
India — Central Drugs Standard Control Organisation: The national drug regulatory authority that will implement the digital platform, enhancing its efficiency and transparency.
Jul 31, 2026 · 7 articles
Business
India: India's healthcare sector benefits from the availability of a new targeted cancer therapy, Tanstrive, which addresses a specific genetic alteration in various solid tumors. This improves treatment options for Indian patients.
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation provided marketing authorization for Tanstrive, enabling its launch in India and ensuring regulatory compliance for the new drug.
Jun 25, 2026 · 7 articles
Regulatory
India: India is the country where the approval was granted; the decision addresses a significant public health burden of fatty liver disease.
India — Central Drugs Standard Control Organisation: The CDSCO is the Indian regulatory body that granted the approval, enabling the expanded use of Wegovy for MASH.
Jul 17, 2026 · 13 articles
Tech
India: India>>> is the country where Zayn Malik>>> was discovered and developed, and where it first received regulatory approval from the India — Central Drugs Standard Control Organisation>>>.
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation>>> approved Zayn Malik>>> for import and marketing in India, providing Wockhardt>>> with a domestic market for its new antibiotic.
May 29, 2026 · 9 articles
Regulatory
India: India's regulatory framework is being tested; the case could clarify the applicability of drug laws to duty-free shops.
India — Central Drugs Standard Control Organisation: CDSCO conducted the inspection and issued the order to discontinue sales; it is enforcing drug regulations.
Jul 07, 2026 · 17 articles
Regulatory
India: India's regulatory body approved a new treatment for MASH, improving healthcare options for patients with liver disease.
India — Central Drugs Standard Control Organisation: CDSCO granted approval for the new indication, enabling Emcure to offer Poviztra for MASH treatment.
Jul 20, 2026 · 8 articles
Regulatory
India: The regulatory changes proposed by the Bangladesh — Ministry of Health and Family Welfare are intended to benefit the medical device industry and patients within India by improving ease of doing business and ensuring timely availability of quality medical devices.
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation is involved as the draft notification for the amendments is available on its website for stakeholder comments.
Jun 28, 2026 · 6 articles
Business
India: India gains access to its first disease-modifying Alzheimer's therapy, addressing a significant dementia burden, though adoption faces challenges.
India — Central Drugs Standard Control Organisation: CDSCO granted marketing authorisation for Leqembi, enabling its launch in India, reflecting its regulatory role.
Aug 03, 2026 · 6 articles
Regulatory
India — Central Drugs Standard Control Organisation: India — Central Drugs Standard Control Organisation launched risk-based inspections of drugs across six states and is analyzing samples to determine the cause of deaths.
Oct 07, 2025 · 7 articles
Regulatory
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation alerted the India — Drugs Control Administration, Telangana, about the adulteration of Almont-Kid Syrup, playing a crucial role in identifying the issue.
Jan 10, 2026 · 6 articles
Regulatory
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation is collaborating with state regulators in India to curb malpractices in the GLP-1 drug supply chain.
Mar 24, 2026 · 11 articles
Regulatory
India — Central Drugs Standard Control Organisation: The India — Central Drugs Standard Control Organisation is responsible for strengthening manufacturing processes and avoiding compliance failures within India's pharmaceutical sector, contributing to the new regulations.
Jun 16, 2026 · 22 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how India and India — Central Drugs Standard Control Organisation interact across events, view sentiment trends, and discover connected entities.
Open Dashboard